Colman M - Search Results

1

Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.

Bitran JD, Desser RK, DeMeester T, Shapiro CM, Billings A, Rubenstein L, Evans R, Colman M, Rao CY, Griem M, Golomb HM. Bitran JD, et al. Among authors: colman m. Cancer Treat Rep. 1978 Mar;62(3):327-32. Cancer Treat Rep. 1978. PMID: 348305 Clinical Trial.

2

Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040).

Bitran J, Golomb HM, Desser RK, Colman M. Bitran J, et al. Among authors: colman m. Cancer Treat Rep. 1976 Mar;60(3):221-3. Cancer Treat Rep. 1976. PMID: 177208 No abstract available.

3

Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.

Bitran JD, Desser RK, DeMeester TR, Colman M, Evans R, Billings A, Griem M, Rubenstein L, Shapiro C, Golomb HM. Bitran JD, et al. Among authors: colman m. Cancer Treat Rep. 1976 Sep;60(9):1225-30. Cancer Treat Rep. 1976. PMID: 189920

4

Small-cell carcinoma of the lung: the prognostic significance of stage on survival.

Cooksey JA, Bitran JD, Desser RK, Kinnealey AE, Mintz U, Colman M, Cimochowski G, Griem ML, Demeester TR, Golomb HM. Cooksey JA, et al. Among authors: colman m. Eur J Cancer (1965). 1979 Jun;15(6):859-65. doi: 10.1016/0014-2964(79)90227-5. Eur J Cancer (1965). 1979. PMID: 499274 No abstract available.

5

Survival of patients with lung cancer treated with vincristine and actinomycin D: An unsuccessful trial.

Bitran J, Billings A, Desser RK, Cohen L, Colman M, Shapiro C. Bitran J, et al. Among authors: colman m. Cancer. 1976 Apr;37(4):1669-72. doi: 10.1002/1097-0142(197604)37:4<1669::aid-cncr2820370409>3.0.co;2-n. Cancer. 1976. PMID: 1260683

6

Radiation therapy in the treatment of malignant salivary gland tumors.

Elkon D, Colman M, Hendrickson FR. Elkon D, et al. Among authors: colman m. Cancer. 1978 Feb;41(2):502-6. doi: 10.1002/1097-0142(197802)41:2<502::aid-cncr2820410217>3.0.co;2-v. Cancer. 1978. PMID: 204407

7

Imaging techniques in breast cancer: workshop report.

Colman M, Mattheiem W. Colman M, et al. Eur J Cancer Clin Oncol. 1988 Jan;24(1):69-71. doi: 10.1016/0277-5379(88)90178-2. Eur J Cancer Clin Oncol. 1988. PMID: 3338489 No abstract available.

8

So-called "malignant blue nevus": a clinicopathologic study of 23 patients.

Martin RC, Murali R, Scolyer RA, Fitzgerald P, Colman MH, Thompson JF. Martin RC, et al. Cancer. 2009 Jul 1;115(13):2949-55. doi: 10.1002/cncr.24319. Cancer. 2009. PMID: 19472395 Free article.

9

Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.

Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y. Azzola MF, et al. Among authors: colman mh. Cancer. 2003 Mar 15;97(6):1488-98. doi: 10.1002/cncr.11196. Cancer. 2003. PMID: 12627514 Free article. Clinical Trial.

10

Angiotropism is an independent predictor of local recurrence and in-transit metastasis in primary cutaneous melanoma.

Van Es SL, Colman M, Thompson JF, McCarthy SW, Scolyer RA. Van Es SL, et al. Among authors: colman m. Am J Surg Pathol. 2008 Sep;32(9):1396-403. doi: 10.1097/PAS.0b013e3181753a8e. Am J Surg Pathol. 2008. PMID: 18670348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters